REMOGLIFLOZIN ETABONATE belongs to the class of antidiabetic drugs, primarily used to treat type 2 diabetes mellitus and non-alcoholic steatohepatitis (non-alcoholic fatty liver disease). Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produce little or no insulin at all. REMOGLIFLOZIN ETABONATE is not indicated for use in type 1 diabetes.
REMOGLIFLOZIN ETABONATE contains Remogliflozin Etabonate. It belongs to the class of gliflozins. It is a sodium-glucose transporter 2 inhibitor and works by reducing blood sugar levels by eliminating excess sugars from the body through urine. Thus, it helps improve the glycaemic control (control of glucose levels) in patients. REMOGLIFLOZIN ETABONATE also lowers the risk of heart failure in type 2 diabetic patients with heart diseases.
Take REMOGLIFLOZIN ETABONATE as advised by your doctor. Some common side effects of REMOGLIFLOZIN ETABONATE include nausea, frequent urge to urinate, low blood sugar levels, fungal infection in the genital area, and increased thirst. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
REMOGLIFLOZIN ETABONATE may cause hypoglycaemia (low blood sugar); hence it advised to take healthy food with enough calories and avoid heavy exercises. Do not take or stop this medicine if the doctor did not advise you to do so. Before starting REMOGLIFLOZIN ETABONATE, let your doctor know if you have any medical history of heart, kidney or liver diseases, breathing problems, blood disorders, dehydration, alcohol use, low blood pressure, and yeast infection of genitals. It is advised to avoid your alcohol intake while using REMOGLIFLOZIN ETABONATE. REMOGLIFLOZIN ETABONATE should be used only when prescribed by a doctor if you are pregnant or breastfeeding.
Type 2 Diabetes mellitus.
REMOGLIFLOZIN ETABONATE treats type 2 diabetes mellitus and contains Remogliflozin Etabonate. It works by reducing blood sugar levels by eliminating excess sugars from the body through urine. REMOGLIFLOZIN ETABONATE also reduces the risk of heart failure in patients with type 2 diabetes and heart disease. REMOGLIFLOZIN ETABONATE may be advised with or without other medications along with diet and exercise to control blood sugar levels.
Inform your doctor if you take other antidiabetic drugs to adjust the dosage of REMOGLIFLOZIN ETABONATE accordingly. Do not abruptly stop taking REMOGLIFLOZIN ETABONATE midway if the doctor did not advise you. REMOGLIFLOZIN ETABONATE may cause hypoglycaemia (low blood sugar); hence it is advised to take healthy food with enough calories and avoid heavy exercises. Brief your medical history to doctor if you have any heart, kidney or liver diseases, breathing problems (asthma, obstructive lung diseases), blood problems like anaemia (lack of blood cells), vitamin B12 deficiency, pancreas problems/surgery, dehydration, alcohol use, low blood pressure, and genital yeast infection before taking REMOGLIFLOZIN ETABONATE. REMOGLIFLOZIN ETABONATE should be used only when prescribed by a doctor if you are pregnant or breastfeeding. Your doctor may advise alternate medications to control your diabetic condition in such cases.
Drug-Drug Interaction: REMOGLIFLOZIN ETABONATE may interact with antibiotics (Fluconazole), drugs treating impotence (Sildenafil), antidiabetics (Glimepiride), and anticonvulsants (Pregabalin).
Drug-Food Interaction: Avoid alcohol intake since it may increase the risk of low blood sugar levels.
Drug-Disease Interaction: Tell your doctor before taking REMOGLIFLOZIN ETABONATE if you have any heart, kidney or liver diseases, breathing problems, blood disorders, dehydration, alcohol use, low blood pressure, and yeast infection of the genitals.
It is advised to avoid alcohol intake since it may worsen the risk of developing low blood sugar levels.
Gliflozins are usually not recommended during the second or third trimester of pregnancy. Your doctor may suggest other medications to control your blood sugar levels. Please consult your doctor before starting REMOGLIFLOZIN ETABONATE if you are pregnant or planning to conceive.
There is limited information on how REMOGLIFLOZIN ETABONATE affects breastfeeding. Please seek medical advice for further information.
Your driving ability may be affected if your blood sugar levels are too high or too low. Do not drive or operate machinery if you also experience blurred vision, dizziness or drowsiness due to extremely low or high blood sugar.
Let your doctor know if you have any history of liver diseases or hepatic impairment when prescribed REMOGLIFLOZIN ETABONATE. Your doctor will prescribe REMOGLIFLOZIN ETABONATE only if the benefit outweighs the risk.
Let your doctor know if you have any history of kidney diseases when you are prescribed REMOGLIFLOZIN ETABONATE. Your doctor will prescribe REMOGLIFLOZIN ETABONATE only if the benefit outweighs the risk.
Your child’s doctor will decide whether to give REMOGLIFLOZIN ETABONATE to children or not.
Diabetes mellitus, also known as adult-onset diabetes, is a metabolic disease that causes high blood sugar levels. It is type 2 diabetes and occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produce little or no insulin at all. This disease mainly occurs in people aged above 40 years but can also occur in childhood based on the risk factors. The treatment includes oral glucose-lowering medicines and insulin shots.